Moreover, H151 reverses the effect of sorafenib-induced USP18 accumulation in HCC cells and enhances the sensitivity of HCC-SR cells to sorafenib (Fig. 5L and Supplementary Fig. S5G). This evidence concerns the gene USP18 and hepatocellular carcinoma.